Sale of shares in BioGaia AB

BioGaia has been informed by Annwall & Rothschild Investments AB (A & R AB), main shareholders in BioGaia, that they due to private financial reasons have sold 130 000 B-shares in BioGaia AB to long term investors. After the sale A & R AB owns 5.6% of the capital and 31.8% of the votes. A & R AB has no intention to sell additional shares in BioGaia in the foreseeable future.

Latest press releases from BioGaia
2019-05-09 Annual General Meeting of BioGaia
2019-05-08 BioGaia AB Interim Management Report 1 January – 31 March 2019
2019-05-06 BioGaia’s probiotic decreases pain in patients with diverticulitis

For additional information please contact
Peter Rothschild, Chairman of the board BioGaia, +46 (0)708 306 540

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com